Japanese drug major Shionogi has announced new data at IDWeek 2024 from PROVE (Retrospective Cefiderocol Chart Review), the largest global real-world evidence study of Fetroja/Fetcroja (cefiderocol), ...
Years of growing resistance to antibiotics have sparked an urgent global health crisis, giving rise to challenging biological threats and the emergence of more dangerous ...
Since announcing the review, business development at Sandoz has continued, for example with the purchase of GSK's cephalosporin business for up to $500 million. The unit is still facing near-term ...
Case Report Overview of Ceftriaxone-Induced Hepatic Panel Abnormalities Discussion Conclusion References Another case report described an 80-year-old man who was hospitalized with painless ...
Growing consciousness amongst consumers of its health advantages in cancer prohibition and detoxification is driving the market demand. Likhil G Polaris Market Research and Consulting + + + +1 929-297 ...